共 2 条
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: Carboxamide derivatives with different spacer motifs
被引:20
|作者:
Eibl, Christoph
[1
,2
]
Munoz, Lenka
[1
,3
]
Tomassoli, Isabelle
[2
]
Stokes, Clare
[4
]
Papke, Roger L.
[4
]
Guendisch, Daniela
[1
,2
]
机构:
[1] Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany
[2] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA
[3] Univ Sydney, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2006, Australia
[4] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
基金:
美国国家科学基金会;
美国国家卫生研究院;
关键词:
3,7-Diazabicyclo[3.3.1]nonane;
Bispidine;
Nicotinic acetylcholine receptor nAChR;
Structure-activity relationship;
Cytisine;
CYTISINE;
AFFINITY;
AGONISTS;
D O I:
10.1016/j.bmc.2013.09.060
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
3,7-Diazabicyclo[3.3.1]nonane (bispidine) based nicotinic acetylcholine receptor (nAChR) ligands have been synthesized and evaluated for nAChRs interaction. Diverse spacer motifs were incorporated between the hydrogen bond acceptor (HBA) part and a variety of substituted (hetero)aryl moieties. Bispidine carboxamides bearing spacer motifs often showed high affinity in the low nanomolar range and selectivity for the alpha 4 beta 2* nAChR. Compounds 15, 25, and 47 with K-i values of about 1 nM displayed the highest affinities for alpha 4 beta 2* nAChR. All evaluated compounds are partial agonists or antagonists at alpha 4 beta 2*, with reduced or no effects on alpha 3 beta 4* with the exception of compound 15 (agonist), and reduced or no effect at alpha 7 and muscle subtypes. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7309 / 7329
页数:21
相关论文